Second edition of Abu Dhabi Poetry Festival launches Monday with diverse cultural programme Final draws to set 2026 stage for AFCU17, U17WAC UAE Team Emirates-XRG’s Jan Christen claims AlUla Tour title Mohammed bin Rashid attends conclusion of Women’s Desert Race at Al Salam Cycling Championship NYUAD researchers develop nanotechnology to improve cancer detection, treatment ICP keen to support innovation, adopt technological solutions Governing Ai and Ai Governing Jay Vine clinches Tour Down Under overall victory for UAE Team Emirates-XRG
Business Middle East - Mebusiness

Healthpoint expands services with addition of Oral, Maxillofacial Surgery

Healthpoint, part of the M42 group, has recently boosted its multi-speciality facility with the introduction of Oral and Maxillofacial Surgery (OMFS). This new specialty is set to enhance the range of services available to patients by offering expert

WHO deeply concerned over violence impacting Lebanon's healthcare

The World Health Organisation (WHO) expressed grave concern regarding the impact of the recent escalation of violence on the healthcare system in Lebanon. In a video press conference, Ian Clarke, WHO Deputy Incident Manager for Lebanon, stated that,

ZHO celebrates World Cerebral Palsy Day

Zayed Higher Organisation for People of Determination (ZHO) emphasised the importance of raising awareness about cerebral palsy. In a statement to mark the World Cerebral Palsy Day, which falls on 6th October every year, aiming to raise awareness and

Doctors at SEHA successfully treat patient with severe lupus

A 14-year-old boy diagnosed with a severe and incurable autoimmune disease has been given a shot at leading a normal life after doctors at SEHA, a subsidiary of PureHealth, were able to intervene early and achieve remission for his disease. The

US Food and Drug Administration approves 'Dupixent' for treatment of bronchitis

The US Food and Drug Administration (FDA) has approved French pharmaceutical company Sanofi's Dupixent, an anti-bronchitis drug for smokers. According to the Washington Post, the drug's approval followed EU and Chinese approval, and was based